Biotechnology Value Fund L P - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of Five Prime Therapeutics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Five Prime Therapeutics Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Five Prime Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Fund L P made 1 insider transaction in Eledon Pharmaceuticals Inc () with a net purchase of 1,978,932. Other recent insider transactions involving Eledon Pharmaceuticals Inc () include a net purchase of 1,000 shares made by Steven Perrin ,

In summary, during the past 3 months, insiders sold 0 shares of Eledon Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eledon Pharmaceuticals Inc () were sold and 1,979,932 shares were bought by its insiders, resulting in a net purchase of 1,979,932 shares.

Eledon Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Fund L P made 3 insider transaction in XOMA Corp () with a net purchase of 103,200. Other recent insider transactions involving XOMA Corp () include a net purchase of 9,100 shares made by Bradley Sitko , a net purchase of 5,500 shares made by Owen Hughes , and a net sale of 25,000 shares made by James R Neal .

In summary, during the past 3 months, insiders sold 0 shares of XOMA Corp () in total and bought 5,250 shares, with a net purchase of 5,250 shares. During the past 18 months, 27,000 shares of XOMA Corp () were sold and 117,800 shares were bought by its insiders, resulting in a net purchase of 90,800 shares.

XOMA Corp ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Fund L P made no insider transaction in Merus NV (). Other recent insider transactions involving Merus NV () include a net sale of 2,058 shares made by Harry Shuman , and a net purchase of 25,576 shares made by Sven Ante Lundberg .

In summary, during the past 3 months, insiders sold 575 shares of Merus NV () in total and bought 0 shares, with a net sale of 575 shares. During the past 18 months, 2,058 shares of Merus NV () were sold and 25,576 shares were bought by its insiders, resulting in a net purchase of 23,518 shares.

Merus NV ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Fund L P made 3 insider transaction in Kymera Therapeutics Inc () with a net purchase of 1,000,637. Other recent insider transactions involving Kymera Therapeutics Inc () include a net sale of 1,017,436 shares made by Bruce Booth , a net sale of 1,017,436 shares made by Atlas Venture Fund X, L.p. , and a net sale of 1,370 shares made by Bruce N. Jacobs .

In summary, during the past 3 months, insiders sold 0 shares of Kymera Therapeutics Inc () in total and bought 414,105 shares, with a net purchase of 414,105 shares. During the past 18 months, 2,036,242 shares of Kymera Therapeutics Inc () were sold and 1,000,637 shares were bought by its insiders, resulting in a net sale of 1,035,605 shares.

Kymera Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Principia Biopharma Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Principia Biopharma Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Principia Biopharma Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Fund L P made no insider transaction in IDEAYA Biosciences Inc (). Other recent insider transactions involving IDEAYA Biosciences Inc () include a net sale of 28,970 shares made by Jason Throne , a net sale of 12,500 shares made by Paul A. Stone , and a net sale of 2,000 shares made by Briseno Andres Ruiz .

In summary, during the past 3 months, insiders sold 6,163 shares of IDEAYA Biosciences Inc () in total and bought 0 shares, with a net sale of 6,163 shares. During the past 18 months, 43,470 shares of IDEAYA Biosciences Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 43,470 shares.

IDEAYA Biosciences Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Fund L P made no insider transaction in Calithera Biosciences Inc (). Other recent insider transactions involving Calithera Biosciences Inc () include a net sale of 121,333 shares made by Deepika Pakianathan ,

In summary, during the past 3 months, insiders sold 0 shares of Calithera Biosciences Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 121,333 shares of Calithera Biosciences Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 121,333 shares.

Calithera Biosciences Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Fund L P made 1 insider transaction in CTI BioPharma Corp () with a net sale of 8,500,000. Other recent insider transactions involving CTI BioPharma Corp () include a net sale of 289,784 shares made by David Kirske , a net sale of 637,140 shares made by Adam R Craig , and a net sale of 203,121 shares made by Michael A Metzger .

In summary, during the past 3 months, insiders sold 0 shares of CTI BioPharma Corp () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 9,735,045 shares of CTI BioPharma Corp () were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 9,730,045 shares.

CTI BioPharma Corp ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Fund L P made no insider transaction in Cytokinetics Inc (). Other recent insider transactions involving Cytokinetics Inc () include a net sale of 362,500 shares made by Robert I Blum , a net sale of 140,800 shares made by Fady Ibraham Malik , and a net sale of 17,186 shares made by Wendall Wierenga .

In summary, during the past 3 months, insiders sold 82,500 shares of Cytokinetics Inc () in total and bought 0 shares, with a net sale of 82,500 shares. During the past 18 months, 638,842 shares of Cytokinetics Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 638,842 shares.

Cytokinetics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Fund L P made no insider transaction in Pieris Pharmaceuticals Inc (). Other recent insider transactions involving Pieris Pharmaceuticals Inc () include a net purchase of 10,000 shares made by Christopher P Kiritsy ,

In summary, during the past 3 months, insiders sold 0 shares of Pieris Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pieris Pharmaceuticals Inc () were sold and 10,000 shares were bought by its insiders, resulting in a net purchase of 10,000 shares.

Pieris Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Fund L P made no insider transaction in GlycoMimetics Inc (). Other recent insider transactions involving GlycoMimetics Inc () include a net purchase of 2,026,717 shares made by Invus Public Equities, L.p. , a net sale of 4,121,511 shares made by Scott D Sandell , and a net purchase of 375,403 shares made by Edwin Rock .

In summary, during the past 3 months, insiders sold 0 shares of GlycoMimetics Inc () in total and bought 65,403 shares, with a net purchase of 65,403 shares. During the past 18 months, 4,125,211 shares of GlycoMimetics Inc () were sold and 2,581,565 shares were bought by its insiders, resulting in a net sale of 1,543,646 shares.

GlycoMimetics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Fund L P made no insider transaction in Concert Pharmaceuticals Inc (). Other recent insider transactions involving Concert Pharmaceuticals Inc () include a net sale of 16,093 shares made by Nancy Stuart , a net sale of 12,999 shares made by James V Cassella , and a net sale of 11,386 shares made by Jeffrey A Munsie .

In summary, during the past 3 months, insiders sold 0 shares of Concert Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 64,643 shares of Concert Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 64,643 shares.

Concert Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Fund L P made no insider transaction in Infinity Pharmaceuticals Inc (). Other recent insider transactions involving Infinity Pharmaceuticals Inc () include a net sale of 410,196 shares made by Adelene Q Perkins , and a net sale of 14,994 shares made by Stephane Peluso .

In summary, during the past 3 months, insiders sold 410,196 shares of Infinity Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 410,196 shares. During the past 18 months, 425,190 shares of Infinity Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 425,190 shares.

Infinity Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Immune Design Corp () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immune Design Corp () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Immune Design Corp ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Fund L P made no insider transaction in Syndax Pharmaceuticals Inc (). Other recent insider transactions involving Syndax Pharmaceuticals Inc () include a net sale of 823,391 shares made by Briggs Morrison , a net sale of 102,670 shares made by Michael A Metzger , and a net sale of 75,069 shares made by Peter Ordentlich .

In summary, during the past 3 months, insiders sold 0 shares of Syndax Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,236,522 shares of Syndax Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,236,522 shares.

Syndax Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Arqule Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Arqule Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Arqule Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Fund L P made no insider transaction in Xenon Pharmaceuticals Inc (). Other recent insider transactions involving Xenon Pharmaceuticals Inc () include a net sale of 327,612 shares made by Simon N. Pimstone , a net sale of 65,231 shares made by Sherrington Robin , and a net sale of 57,743 shares made by James R. Empfield .

In summary, during the past 3 months, insiders sold 0 shares of Xenon Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 527,290 shares of Xenon Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 527,290 shares.

Xenon Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Regulus Therapeutics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Regulus Therapeutics Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Regulus Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Capstone Holding Corp () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Capstone Holding Corp () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Capstone Holding Corp ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Fund L P made no insider transaction in Alpine Immune Sciences Inc (). Other recent insider transactions involving Alpine Immune Sciences Inc () include a net sale of 89,514 shares made by James Paul Rickey , a net purchase of 375,000 shares made by Xiangmin Cui , and a net purchase of 375,000 shares made by .

In summary, during the past 3 months, insiders sold 89,514 shares of Alpine Immune Sciences Inc () in total and bought 750,000 shares, with a net purchase of 660,486 shares. During the past 18 months, 89,514 shares of Alpine Immune Sciences Inc () were sold and 750,000 shares were bought by its insiders, resulting in a net purchase of 660,486 shares.

Alpine Immune Sciences Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Cascadian Therapeutics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cascadian Therapeutics Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Cascadian Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Fund L P made no insider transaction in ChemoCentryx Inc (). Other recent insider transactions involving ChemoCentryx Inc () include a net sale of 66,196 shares made by Susan M Kanaya , a net sale of 130,000 shares made by Thomas J. Schall , and a net sale of 3,863 shares made by James L Tyree .

In summary, during the past 3 months, insiders sold 0 shares of ChemoCentryx Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 200,059 shares of ChemoCentryx Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 200,059 shares.

ChemoCentryx Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Fund L P made no insider transaction in Catalyst Biosciences Inc (). Other recent insider transactions involving Catalyst Biosciences Inc () include a net purchase of 3,250 shares made by Seline E. Miller , a net purchase of 3,250 shares made by Nassim Usman , and a net purchase of 3,250 shares made by Grant E. Blouse .

In summary, during the past 3 months, insiders sold 0 shares of Catalyst Biosciences Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Catalyst Biosciences Inc () were sold and 9,750 shares were bought by its insiders, resulting in a net purchase of 9,750 shares.

Catalyst Biosciences Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Fund L P made no insider transaction in Ligand Pharmaceuticals Inc (). Other recent insider transactions involving Ligand Pharmaceuticals Inc () include a net sale of 26,000 shares made by John L Higgins , a net sale of 10,852 shares made by John W Kozarich , and a net sale of 6,408 shares made by Stephen L Sabba .

In summary, during the past 3 months, insiders sold 0 shares of Ligand Pharmaceuticals Inc () in total and bought 4,000 shares, with a net purchase of 4,000 shares. During the past 18 months, 45,256 shares of Ligand Pharmaceuticals Inc () were sold and 4,000 shares were bought by its insiders, resulting in a net sale of 41,256 shares.

Ligand Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Regado Biosciences Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Regado Biosciences Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Regado Biosciences Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Fund L P made no insider transaction in Palatin Technologies Inc (). Other recent insider transactions involving Palatin Technologies Inc () include a net sale of 400 shares made by Alan W Dunton , a net purchase of 10,000 shares made by Carl Spana , and a net purchase of 10,000 shares made by Stephen T Wills .

In summary, during the past 3 months, insiders sold 200 shares of Palatin Technologies Inc () in total and bought 0 shares, with a net sale of 200 shares. During the past 18 months, 400 shares of Palatin Technologies Inc () were sold and 20,000 shares were bought by its insiders, resulting in a net purchase of 19,600 shares.

Palatin Technologies Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Fund L P made no insider transaction in Rigel Pharmaceuticals Inc (). Other recent insider transactions involving Rigel Pharmaceuticals Inc () include a net purchase of 979,660 shares made by Raul R Rodriguez , a net sale of 5,389 shares made by Wolfgang Dummer , and a net sale of 5,389 shares made by Dean L Schorno .

In summary, during the past 3 months, insiders sold 0 shares of Rigel Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 36,506 shares of Rigel Pharmaceuticals Inc () were sold and 1,000,000 shares were bought by its insiders, resulting in a net purchase of 963,494 shares.

Rigel Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Fund L P made no insider transaction in Neurocrine Biosciences Inc (). Other recent insider transactions involving Neurocrine Biosciences Inc () include a net sale of 49,018 shares made by Julie Cooke , a net sale of 70,576 shares made by Darin Lippoldt , and a net sale of 111,878 shares made by Eric Benevich .

In summary, during the past 3 months, insiders sold 24,687 shares of Neurocrine Biosciences Inc () in total and bought 0 shares, with a net sale of 24,687 shares. During the past 18 months, 540,738 shares of Neurocrine Biosciences Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 540,738 shares.

Neurocrine Biosciences Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of EPIRUS Biopharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of EPIRUS Biopharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

EPIRUS Biopharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Fund L P made no insider transaction in MediciNova Inc (). Other recent insider transactions involving MediciNova Inc () include a net sale of 12,646 shares made by Hideki Nagao ,

In summary, during the past 3 months, insiders sold 0 shares of MediciNova Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 12,646 shares of MediciNova Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 12,646 shares.

MediciNova Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Neurobiological Technologies Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Neurobiological Technologies Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Neurobiological Technologies Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Fund L P made no insider transaction in Dynavax Technologies Corp (). Other recent insider transactions involving Dynavax Technologies Corp () include a net sale of 275,969 shares made by David F Novack , a net sale of 58,115 shares made by Robert Janssen , and a net sale of 7,500,000 shares made by Hack Andrew A. F. .

In summary, during the past 3 months, insiders sold 106,770 shares of Dynavax Technologies Corp () in total and bought 0 shares, with a net sale of 106,770 shares. During the past 18 months, 7,913,109 shares of Dynavax Technologies Corp () were sold and 0 shares were bought by its insiders, resulting in a net sale of 7,913,109 shares.

Dynavax Technologies Corp ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Fund L P made no insider transaction in Repligen Corp (). Other recent insider transactions involving Repligen Corp () include a net sale of 76,204 shares made by Anthony Hunt , a net sale of 14,345 shares made by Jon Snodgres , and a net sale of 7,145 shares made by Christine Gebski .

In summary, during the past 3 months, insiders sold 3,788 shares of Repligen Corp () in total and bought 0 shares, with a net sale of 3,788 shares. During the past 18 months, 106,159 shares of Repligen Corp () were sold and 1,500 shares were bought by its insiders, resulting in a net sale of 104,659 shares.

Repligen Corp ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Curis Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Curis Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Curis Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Aeolus Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aeolus Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Aeolus Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of AMAG Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of AMAG Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

AMAG Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Arena Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Arena Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Arena Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Fund L P made no insider transaction in BioCryst Pharmaceuticals Inc (). Other recent insider transactions involving BioCryst Pharmaceuticals Inc () include a net sale of 411,673 shares made by Jon P Stonehouse , a net sale of 10,125 shares made by Helen M. Thackray , and a net sale of 9,045 shares made by Michael L Jones .

In summary, during the past 3 months, insiders sold 0 shares of BioCryst Pharmaceuticals Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 495,199 shares of BioCryst Pharmaceuticals Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 495,199 shares.

BioCryst Pharmaceuticals Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of XOMA Corp () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of XOMA Corp () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

XOMA Corp ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Fund L P made no insider transaction in CytomX Therapeutics Inc (). Other recent insider transactions involving CytomX Therapeutics Inc () include a net sale of 36,633 shares made by Sean A. Mccarthy , a net sale of 13,125 shares made by Lloyd A Rowland , and a net sale of 9,802 shares made by Jeffrey B Landau .

In summary, during the past 3 months, insiders sold 28,325 shares of CytomX Therapeutics Inc () in total and bought 0 shares, with a net sale of 28,325 shares. During the past 18 months, 87,214 shares of CytomX Therapeutics Inc () were sold and 5,000 shares were bought by its insiders, resulting in a net sale of 82,214 shares.

CytomX Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Fund L P made no insider transaction in Verastem Inc (). Other recent insider transactions involving Verastem Inc () include a net sale of 2,066 shares made by Daniel Calkins , a net sale of 52,591 shares made by Brian M Stuglik , and a net sale of 30,444 shares made by Dan Paterson .

In summary, during the past 3 months, insiders sold 1,845 shares of Verastem Inc () in total and bought 0 shares, with a net sale of 1,845 shares. During the past 18 months, 107,776 shares of Verastem Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 107,776 shares.

Verastem Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Fund L P made 1 insider transaction in Rain Oncology Inc () with a net purchase of 1,710,358. Other recent insider transactions involving Rain Oncology Inc () include a net purchase of 1,372,418 shares made by Kevin C Tang , a net purchase of 164,881 shares made by Franklin M Berger , and a net sale of 995,000 shares made by Boxer Capital, Llc .

In summary, during the past 3 months, insiders sold 0 shares of Rain Oncology Inc () in total and bought 284,145 shares, with a net purchase of 284,145 shares. During the past 18 months, 995,000 shares of Rain Oncology Inc () were sold and 4,219,869 shares were bought by its insiders, resulting in a net purchase of 3,224,869 shares.

Rain Oncology Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Fund L P made 2 insider transaction in Olema Pharmaceuticals inc () with a net purchase of 1,705,932. Other recent insider transactions involving Olema Pharmaceuticals inc () include a net sale of 163,181 shares made by Cyrus Harmon , a net sale of 44,370 shares made by David C. Myles , and a net sale of 8,742 shares made by Kovacs Shane William Charles .

In summary, during the past 3 months, insiders sold 223,074 shares of Olema Pharmaceuticals inc () in total and bought 1,505,932 shares, with a net purchase of 1,282,858 shares. During the past 18 months, 298,074 shares of Olema Pharmaceuticals inc () were sold and 1,715,932 shares were bought by its insiders, resulting in a net purchase of 1,417,858 shares.

Olema Pharmaceuticals inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Fund L P made no insider transaction in Cullinan Oncology Inc (). Other recent insider transactions involving Cullinan Oncology Inc () include a net sale of 30,883 shares made by Jennifer Michaelson , a net sale of 2,579 shares made by Jeffrey Trigilio , and a net sale of 2,888 shares made by Nadim Ahmed .

In summary, during the past 3 months, insiders sold 0 shares of Cullinan Oncology Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 250,903 shares of Cullinan Oncology Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 250,903 shares.

Cullinan Oncology Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Fund L P made 3 insider transaction in Repare Therapeutics Inc () with a net purchase of 2,160,171. Other recent insider transactions involving Repare Therapeutics Inc () include a net sale of 10,473 shares made by Michael Zinda , a net sale of 250,000 shares made by Davis Jerel ,

In summary, during the past 3 months, insiders sold 0 shares of Repare Therapeutics Inc () in total and bought 2,011,010 shares, with a net purchase of 2,011,010 shares. During the past 18 months, 260,473 shares of Repare Therapeutics Inc () were sold and 2,160,171 shares were bought by its insiders, resulting in a net purchase of 1,899,698 shares.

Repare Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Fund L P made no insider transaction in MoonLake Immunotherapeutics (). Other recent insider transactions involving MoonLake Immunotherapeutics () include a net purchase of 1,629,151 shares made by Bihua Chen ,

In summary, during the past 3 months, insiders sold 0 shares of MoonLake Immunotherapeutics () in total and bought 352,051 shares, with a net purchase of 352,051 shares. During the past 18 months, 0 shares of MoonLake Immunotherapeutics () were sold and 1,629,151 shares were bought by its insiders, resulting in a net purchase of 1,629,151 shares.

MoonLake Immunotherapeutics ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Fund L P made no insider transaction in 4D Molecular Therapeutics Inc (). Other recent insider transactions involving 4D Molecular Therapeutics Inc () include a net sale of 140,847 shares made by David Kirn , a net sale of 11,998 shares made by Scott Bizily , and a net purchase of 850,000 shares made by Viking Global Investors Lp .

In summary, during the past 3 months, insiders sold 0 shares of 4D Molecular Therapeutics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 157,845 shares of 4D Molecular Therapeutics Inc () were sold and 850,000 shares were bought by its insiders, resulting in a net purchase of 692,155 shares.

4D Molecular Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Fund L P made no insider transaction in ESSA Pharma Inc (). Other recent insider transactions involving ESSA Pharma Inc () include a net purchase of 2,888,869 shares made by Biotech Growth N V , a net purchase of 99,730 shares made by Franklin M Berger , and a net purchase of 24,434 shares made by David Ross Parkinson .

In summary, during the past 3 months, insiders sold 0 shares of ESSA Pharma Inc () in total and bought 99,730 shares, with a net purchase of 99,730 shares. During the past 18 months, 0 shares of ESSA Pharma Inc () were sold and 3,013,033 shares were bought by its insiders, resulting in a net purchase of 3,013,033 shares.

ESSA Pharma Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Fund L P made 1 insider transaction in Third Harmonic Bio Inc () with a net purchase of 214,063. Other recent insider transactions involving Third Harmonic Bio Inc () include a net purchase of 300,000 shares made by Orbimed Advisors Llc , a net purchase of 300,000 shares made by Atlas Venture Fund Xi, L.p. , and a net purchase of 300,000 shares made by David P Bonita .

In summary, during the past 3 months, insiders sold 0 shares of Third Harmonic Bio Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Third Harmonic Bio Inc () were sold and 1,114,063 shares were bought by its insiders, resulting in a net purchase of 1,114,063 shares.

Third Harmonic Bio Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Structure Therapeutics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Structure Therapeutics Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Structure Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Biotechnology Value Fund L P made no insider transaction in POINT Biopharma Global Inc (). Other recent insider transactions involving POINT Biopharma Global Inc () include a net purchase of 50,000 shares made by Allan C Silber , a net purchase of 6,000 shares made by Jonathan R. Goodman , and a net purchase of 3,700 shares made by Rajesh Malik .

In summary, during the past 3 months, insiders sold 0 shares of POINT Biopharma Global Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of POINT Biopharma Global Inc () were sold and 70,830 shares were bought by its insiders, resulting in a net purchase of 70,830 shares.

POINT Biopharma Global Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.